Market access update
Driving market access success in the US
Pharmaceutical market access requirements vary greatly by payer archetype in the US.
To help manufacturers navigate this diverse landscape we have developed robust value assessment frameworks that integrate into the PRMA Healthcheck® digital application. Driving market access success in the US.
The PRMA Healthcheck® assessment frameworks are based on extensive primary and secondary research with more than 30 of the top US managed care organizations, pharmacy benefit managers, and integrated delivery networks.
This enables leading pharmaceutical manufacturers to:
- assess market access and commercialization risks, opportunities, and evidence needs across a wide range of US payers and payer archetypes
- align global and local thinking across rapidly dynamic markets
- apply a consistent, structured assessment process to the diverse US market access landscape
- ensure that evidence packages include key data to achieve successful market access and commercialization of assets.
Drive readiness for payer submissions for your Phase 2 and 3 products